Pfizer Pharmacokinetic Test Studies v2

Paul Jones made this Official Information request to Ministry of Health

The request was refused by Ministry of Health.

From: Paul Jones

Dear Ministry of Health,

Please advise the date the NZ government and its departments received Pharmacokinetic test/study data from Pfizer for the Comirnaty vaccine.

What animals were used in this study?

Yours faithfully,

Paul Jones

Link to this

From: Medsafe


Attachment image001.png
6K Download


Dear Paul
In answer to your queries;
Please advise the date the NZ government and its departments received
Pharmacokinetic test/study data from Pfizer for the Comirnaty vaccine.
You can search for when applications were recieved here
- [1]https://www.medsafe.govt.nz/regulatory/D...

[2]Product/Application Search - Medsafe
Revised: 31 May 2019. Medicines Product/Application Search. Note: While
the status of an application may show ‘Evaluation complete’, ‘Granted’ or
‘Information requested’, it may be 1-2 days before an applicant receives
formal notification (and associated documentation) by email.
www.medsafe.govt.nz

What animals were used in this study?
You can view the full animal study data from a link on this page - 
[3]https://www.pfizer.com/news/press-releas...

[4]Pfizer and BioNTech Announce Data from Preclinical Studies of
mRNA-based Vaccine Candidate Against COVID-19 | pfpfizeruscom
Immunization of non-human primates (rhesus macaques) with BNT162b2, a
nucleoside-modified messenger RNA (modRNA) candidate that expresses the
SARS-CoV-2 spike glycoprotein, resulted in strong anti-viral effects
against an infectious SARS-CoV-2 challenge BNT162b2 immunization prevented
lung infection in 100% of the SARS-CoV-2 challenged rhesus macaques, with
no viral RNA detected in the lower ...
www.pfizer.com

I hope this answers your queries.
Kind regards
Becci

--------------------------------------------------------------------------

From: COVID-19 Vaccine <[email address]>
Sent: Friday, 9 July 2021 1:42 PM
To: Medsafe <[email address]>
Cc: Ollie Penno <[email address]>; OIA Requests
<[email address]>; Susan Kenyon <[email address]>
Subject: RE: Official Information request - Pfizer Pharmacokinetic Test
Studies v2
 

Kia Ora Alex,

 

Vaccine team doesn’t hold information on the below query.

 

[5]@Medsafe can your team assist with the below query please?

 

Ngâ mihi,

Zainab Thameem

Coordinator l  Business Support l COVID-19 Vaccine and Immunisation
Programme

Manatû Hauora l Ministry of Health

 

 

 

From: OIA Requests <[6][email address]>
Sent: Friday, 9 July 2021 11:56 am
To: COVID-19 Vaccine <[7][email address]>; Ollie Penno
<[8][email address]>
Subject: Fw: Official Information request - Pfizer Pharmacokinetic Test
Studies v2

 

Kia ora team,

 

Could someone please respond directly to the question below? It's not an
OIA

 

Thank you

Alex

 

------------------------------------------------------------------------

From: Paul Jones <

Sent: Thursday, 8 July 2021 14:20

To: OIA Requests <[9][email address]>
Subject: Official Information request - Pfizer Pharmacokinetic Test
Studies v2

 

Dear Ministry of Health,

Please advise the date the NZ government and its departments received
Pharmacokinetic test/study data from Pfizer for the Comirnaty vaccine.

What animals were used in this study?

Yours faithfully,

Paul Jones

-------------------------------------------------------------------

This is an Official Information request made via the FYI website.

Please use this email address for all replies to this request:
[10][FOI #16013 email]

Is [11][Ministry of Health request email] the wrong address for Official Information
requests to Ministry of Health? If so, please contact us using this form:
[12]https://scanmail.trustwave.com/?c=15517&...

Disclaimer: This message and any reply that you make will be published on
the internet. Our privacy and copyright policies:
[13]https://scanmail.trustwave.com/?c=15517&...

If you find this service useful as an Official Information officer, please
ask your web manager to link to us from your organisation's OIA or LGOIMA
page.

-------------------------------------------------------------------

****************************************************************************
Statement of confidentiality: This e-mail message and any accompanying
attachments may contain information that is IN-CONFIDENCE and subject to
legal privilege.
If you are not the intended recipient, do not read, use, disseminate,
distribute or copy this message or attachments.
If you have received this message in error, please notify the sender
immediately and delete this message.
****************************************************************************

--------------------------------------------------------------------------

This e-mail message has been scanned for Viruses and Content and cleared
by the Ministry of Health's Content and Virus Filtering Gateway

--------------------------------------------------------------------------

References

Visible links
1. https://www.medsafe.govt.nz/regulatory/D...
2. https://www.medsafe.govt.nz/regulatory/D...
3. https://www.pfizer.com/news/press-releas...
4. https://www.pfizer.com/news/press-releas...
5. mailto:[email address]
6. mailto:[email address]
7. mailto:[email address]
8. mailto:[email address]
9. mailto:[email address]
10. mailto:[FOI #16013 email]
11. mailto:[Ministry of Health request email]
12. https://scanmail.trustwave.com/?c=15517&...
13. https://scanmail.trustwave.com/?c=15517&...

hide quoted sections

Link to this

Things to do with this request

Anyone:
Ministry of Health only: